You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/06/19 | 8-K | Current report filing |
|
10 | |
| 10/22/19 | 8-K | Current report filing |
|
5 | |
| 10/21/19 | 8-K | Current report filing |
|
9 | |
| 10/17/19 | 8-K | Current report filing |
|
6 | |
| 10/15/19 | EFFECT | Notice of Effectiveness |
|
1 | |
| 10/10/19 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 10/09/19 | UPLOAD | SEC-generated letter |
|
1 | |
| 10/07/19 | 424B7 | Prospectus filed pursuant to Rule 424(b)(7) |
|
2 | |
| 10/07/19 | 8-K | Current report filing |
|
8 | |
| 10/04/19 | S-3 | Registration statement for specified transactions by certain issuers |
|
100 |
